VeroScience LLC
Tiverton, RI, US· latest recorded location
VeroScience LLC is named on 42 US grants and 56 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 42
- Published applications
- 56
- Inventors
- 8
- Granted in 2026 so far
- 2
- Most recent grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 2 |
| 2010 | 0 | 1 |
| 2011 | 0 | 3 |
| 2012 | 3 | 2 |
| 2013 | 2 | 2 |
| 2014 | 3 | 4 |
| 2015 | 2 | 3 |
| 2016 | 4 | 4 |
| 2017 | 2 | 5 |
| 2018 | 5 | 5 |
| 2019 | 2 | 3 |
| 2020 | 3 | 2 |
| 2021 | 3 | 6 |
| 2022 | 2 | 4 |
| 2023 | 3 | 4 |
| 2024 | 2 | 1 |
| 2025 | 4 | 2 |
| 2026 | 2 | 2 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 98 documents
- A61KMedicines and medical preparations96
- A61PTherapeutic uses of medicines87
- C07CAcyclic or carbocyclic compounds13
- C07DHeterocyclic compounds13
- A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for6
- A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or6
- G01NInvestigating or analysing materials by determining their chemical or physical properties6
- Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests6
- Y10TTechnical subjects covered by former us classification6
- A61BMedical diagnosis and surgery2
Recent patents
- Composition and method for treating metabolic disorders30 Jun 2026US 12,668,590 B2
- Bromocriptine formulations5 May 2026US 12,616,693 B2
- Composition and method for treating metabolic disorders9 Dec 2025US 12,492,198 B2
- Method for inducing tumor regression15 Jul 2025US 12,357,693 B2
- Method for inducing tumor regression3 Jun 2025US 12,318,451 B2
- Composition and Method for Treating Metabolic Disorders17 Sep 2026US 2026/0274834 A1
- Composition and Method for Treating Metabolic Disorders5 Mar 2026US 2026/0062409 A1
- Bromocriptine formulations4 Sep 2025US 2025/0275961 A1
- Method for inducing tumor regression28 Aug 2025US 2025/0269029 A1
- Bromocriptine formulations25 Apr 2024US 2024/0131026 A1
Most cited
By later US patents
- Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders37US 8,821,915 B22014
- Bromocriptine formulations34US 8,431,155 B12013
- Parenteral formulations of dopamine agonists33US 8,741,918 B22014
- Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof32US 8,137,992 B22012
- Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof32US 8,137,993 B22012